Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanxia Wang

Showing results (341-350 of 356) with videos related to

Pageof 36
Sort By:
Stroke|June 3, 2022
Effect of Hypertension on Efficacy and Safety of Ticagrelor-Aspirin Versus Clopidogrel-Aspirin in Minor Stroke or Transient Ischemic AttackAnxin Wang, Xia Meng, Xue Tian, et al.
Vaccines|May 7, 2025
Safety and Immunogenicity of a New Rotavirus-Inactivated Vaccine in the Chinese Adolescent Population: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical TrialYan Liu, Guangwei Feng, Jinyuan Wu, et al.
Vaccine|July 9, 2022
Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects ≥3 years: A randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trialYuhui Zhang, Yanxia Wang, Chunyu Jia, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 15, 2026
GloPath: An Entity-Centric Foundation Model for Glomerular Lesion Assessment and Clinicopathological InsightsQiming He, Jing Li, Tian Guan, et al.
The New England Journal of Medicine|December 29, 2023
Dual Antiplatelet Treatment up to 72 Hours after Ischemic StrokeYing Gao, Weiqi Chen, Yuesong Pan, et al.
JAMA Neurology|May 28, 2024
Immediate- or Delayed-Intensive Statin in Acute Cerebral Ischemia: The INSPIRES Randomized Clinical TrialYing Gao, Lingling Jiang, Yuesong Pan, et al.
The Lancet. Infectious Diseases|October 18, 2020
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trialShengli Xia, Yuntao Zhang, Yanxia Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2024
Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2Heike Schönherr, Pelin Ayaz, Alexander M Taylor, et al.
Cancer Cell|August 19, 2025
Long-range cholinergic input promotes glioblastoma progressionYang Yang, Chuanyan Yang, Xuezhu Chen, et al.
JAMA|August 14, 2020
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical TrialsShengli Xia, Kai Duan, Yuntao Zhang, et al.
Pageof 36

Showing results (341-350 of 356) with videos related to

Sort By:
Pageof 36
Stroke|June 3, 2022
Effect of Hypertension on Efficacy and Safety of Ticagrelor-Aspirin Versus Clopidogrel-Aspirin in Minor Stroke or Transient Ischemic AttackAnxin Wang, Xia Meng, Xue Tian, et al.
Vaccines|May 7, 2025
Safety and Immunogenicity of a New Rotavirus-Inactivated Vaccine in the Chinese Adolescent Population: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical TrialYan Liu, Guangwei Feng, Jinyuan Wu, et al.
Vaccine|July 9, 2022
Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects ≥3 years: A randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trialYuhui Zhang, Yanxia Wang, Chunyu Jia, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 15, 2026
GloPath: An Entity-Centric Foundation Model for Glomerular Lesion Assessment and Clinicopathological InsightsQiming He, Jing Li, Tian Guan, et al.
The New England Journal of Medicine|December 29, 2023
Dual Antiplatelet Treatment up to 72 Hours after Ischemic StrokeYing Gao, Weiqi Chen, Yuesong Pan, et al.
JAMA Neurology|May 28, 2024
Immediate- or Delayed-Intensive Statin in Acute Cerebral Ischemia: The INSPIRES Randomized Clinical TrialYing Gao, Lingling Jiang, Yuesong Pan, et al.
The Lancet. Infectious Diseases|October 18, 2020
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trialShengli Xia, Yuntao Zhang, Yanxia Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2024
Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2Heike Schönherr, Pelin Ayaz, Alexander M Taylor, et al.
Cancer Cell|August 19, 2025
Long-range cholinergic input promotes glioblastoma progressionYang Yang, Chuanyan Yang, Xuezhu Chen, et al.
JAMA|August 14, 2020
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical TrialsShengli Xia, Kai Duan, Yuntao Zhang, et al.
Pageof 36